WeVote

Bill

Bill

HF 1810

Commissioner of health required to establish a provider orders for life-sustaining treatment program, rulemaking authorized, data classified, immunity established for certain acts, and money appropriated.

2025-2026 Regular Session Introduced by John Huot

Establishes a standardized POLST program to document and honor patient life-sustaining treatment preferences across care settings.

Introduction and first reading, referred to Health Finance and Policy
0
WeVote Research Nonpartisan
Bill Summary · HF 1810

Summary of HF 1810 (2025-2026) – Minnesota

Overview

HF 1810 proposes actions related to the establishment of a state program under the Commissioner of Health for provider orders for life-sustaining treatment (POLST). The bill authorizes rulemaking, clarifies data classifications, provides immunity for certain acts, and includes appropriations to support the program. The primary aim is to create a standardized framework for life-sustaining treatment orders that reflect patient preferences, with oversight and guidance from the Minnesota Department of Health.

Purpose and intent

  • Establish a formal POLST program under the Commissioner of Health.
  • Provide a standardized mechanism for patients to document preferences for life-sustaining treatments across care settings.
  • Ensure clarity, consistency, and accessibility of treatment orders to healthcare providers, patients, and surrogate decision-makers.
  • Support ethical and patient-centered end-of-life and serious illness decision-making.

Key provisions and changes

1) Establishment of a POLST program

  • The Commissioner of Health is required to establish a program governing provider orders for life-sustaining treatment.
  • The program is intended to standardize how clinicians document, communicate, and honor patient treatment preferences.

2) Rulemaking authority

  • The bill authorizes rulemaking to implement and administer the POLST program.
  • Rules may address: form standards, documentation, process for creating and updating orders, and interfacing with other health information systems.

3) Data classification and privacy

  • Data created or maintained under the POLST program would be classified in a manner specified by the bill.
  • Provisions likely define who may access POLST data, how it is stored, and privacy protections, aligning with state health information privacy laws.

4) Immunity

  • The bill establishes immunity for certain acts related to the POLST program.
  • Immunity provisions typically protect healthcare providers, entities, or individuals acting in good faith to implement, honor, or communicate POLST orders, to reduce fear of liability when following patient wishes.

5) Appropriations

  • The bill includes money appropriations (funding) to support the POLST program.
  • Funding would cover administrative costs, rulemaking activities, education and outreach, data management, and implementation efforts.

Who would be affected

  • Commissioner of Health: Responsible for establishing and administering the POLST program, rulemaking, and program oversight.
  • Healthcare providers and facilities: Encouraged or required to follow standardized POLST orders; may need to participate in training and use of standardized forms.
  • Patients and surrogates: Individuals with decisions about life-sustaining treatment would benefit from clearer, standardized documentation of preferences.
  • Health information systems and providers: Data from POLST documents would be integrated, with defined privacy standards and access rules.
  • Public health and legal community: Immunity and regulatory provisions could influence medical liability considerations and professional practice.

Procedural and timeline aspects

  • Introduction and referral: Introduced and referred to the Health Finance and Policy committee (as of March 3, 2025).
  • Next steps: If advanced, the bill would proceed through committee hearings, potential amendments, and floor votes, with rulemaking processes to be defined and implemented following legislative approval.
  • Effective date: The bill text would specify effective dates for program creation, rule publication, and any phased implementation; not provided in the summary, but typically follows after enactment or a defined effective date.

Observations for readers

  • The bill emphasizes patient-centered care by standardizing how life-sustaining treatment preferences are recorded and followed.
  • It creates protective immunity for good-faith actions, potentially reducing liability concerns for clinicians and institutions.
  • The actual scope, such as which health settings are covered (hospitals, hospice, long-term care) and the specific form standards, would be detailed in the rulemaking phase and accompanying administrative rules.

If you’d like, I can tailor this summary to emphasize specific stakeholder perspectives (patients, providers, facilities) or pull in related Minnesota POLST or advance care planning initiatives for comparison.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.